Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2008

View Archived Issues

Genz-29155 and sirolimus combination synergistic in renal transplant model

Studies reveal neurological effects of berberine

Effects of LY-450139 on Abeta studied with novel labeling agent 13C6-leucine

Durable safety and efficacy seen with belatacept in phase II study

Studies report efficacy of alternative regimens of enteric-coated mycophenolate in transplantation

Superior characteristics of P2Y12 inhibitor PRT-060128 detailed

Novel therapeutic agents for neurological disorders divulged in recent patents

GlaxoSmithKline reports on efforts to identify GlyT-1 inhibitors for schizophrenia

Baxter enters U.S. licensing agreement for Innocoll's gentamicin surgical implant for SSIs

FDA reports two new cases of PML in patients receiving Tysabri as monotherapy for MS

Novavax presents favorable results from phase I/IIa pandemic influenza vaccine trial

New treatment options for cancer reported in recent patent literature

CE mark for Cypher Select Plus in acute myocardial infarction

Phase IIa study of CK-1827452 successfully completes interim safety analysis

Recent Novartis patent describes new agents for respiratory disorders

Cell Genesys terminates VITAL-2 GVAX trial in advanced prostate cancer

Genmab to initiate four ofatumumab studies

M2e universal influenza vaccine candidate shows safety and immunogenicity

NexMed decides not to submit NDA for NM-100060

Pain Therapeutics and King Pharmaceuticals develop a new abuse-resistant pain medication

Photocure presents positive phase II results with Visonac for acne

Protherics commences phase IIa Prolarix study in liver cancer

Algeta presents phase II data on pain palliation with alpharadin

Arana completes enrollment in phase II ART-621 trial in psoriasis

Merck and Intercell commence phase II clinical trial of V-710 in S. aureus infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...